Novel-T Revenue and Competitors

Claim your profile

Enschede, Netherlands

Location

N/A

Total Funding

NonProfit

Industry

Estimated Revenue & Valuation

  • Novel-T's estimated annual revenue is currently $7.5M per year.(i)
  • Novel-T's estimated revenue per employee is $97,403

Employee Data

  • Novel-T has 77 Employees.(i)
  • Novel-T grew their employee count by 7% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.5M10019%N/AN/A
#2
$7.5M767%N/AN/A
#3
$3.5M7816%N/AN/A
#4
$7.5M777%N/AN/A
#5
$7.5M53-10%N/AN/A
#6
N/A8343%N/AN/A
#7
$7.5M8211%N/AN/A
#8
$7.5M11045%N/AN/A
#9
$7.5M1297%N/AN/A
#10
$3.5M38-12%N/AN/A

Today, everything is possible. Thanks to high-tech innovation, there's a world of new opportunities for groundbreaking services and revolutionary products. Novel-T is building an environment in which entrepreneurs can grab hold of those opportunities and become game changers. By connecting and activating talent, knowledge, capital, networks and infrastructure, we're making the impossible possible. The Novel-T Foundation's mission is to further develop an innovative entrepreneur's climate in the region of Twente. We do that by investing in three productlines: Support and support systems for innovative startups: from coaching programs and events, to financing Industrial innovation: joint innovation projects between SMEs, local industries and universities Attractive Business Climate: create the right environment for innovative businesses and attract new businesses for Twente. The foundation is a joint initiative of the University of Twente, the City of Enschede, the Region of Twente, the Province of Overijssel and the Saxion University of Applied Sciences. Through Novel-T they share the economic development goal of creating 10.000 new jobs for the region.

keywords:N/A

N/A

Total Funding

77

Number of Employees

$7.5M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Novel-T News

2022-04-19 - Michael Dirda picks mystery novels you won't find on the ...

Those words — the sort a publicist might splash across a paperback's front cover — virtually guaranteed that I wouldn't be adding Ware's...

2022-04-17 - Novel CAR T Therapy for Solid Tumors: 'Exciting Advance'

This novel CAR T therapy, delivered as monotherapy and in combination with an mRNA vaccine engineered to boost T-cell responses,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$18.9M77-9%N/A
#2
$7.9M7939%N/A
#3
$7.5M9212%N/A
#4
$23.9M94161%N/A
#5
$15M95102%N/A